Why Compare Wegovy and Mounjaro Through Private Prescription?
Private vs NHS Route: Wegovy and Mounjaro Difference in Access
Understanding the Wegovy and Mounjaro difference becomes academic if you're stuck on NHS waiting lists for specialist weight management services. The NHS route typically requires GP referral, meeting strict BMI criteria, demonstrating 12-week commercial weight loss attempts, then waiting 6+ months for tier 3 services. Private prescription through EverydayMeds eliminates these barriers - both Wegovy and Mounjaro are available through our 3-minute clinical assessment, with prescriber review completed within 24 hours using our express service.
The key Wegovy and Mounjaro difference lies in their mechanisms: Wegovy contains semaglutide, targeting GLP-1 receptors to reduce appetite and slow gastric emptying. Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors for potentially enhanced glucose control alongside weight management. Both require clinical assessment, but private prescription allows you to discuss these differences with qualified prescribers without lengthy NHS delays or postcode lottery variations in service availability.
Wegovy and Mounjaro Difference: Pricing and Value Comparison
When evaluating the Wegovy and Mounjaro difference through private prescription, transparent pricing helps inform your decision. EverydayMeds offers Wegovy starting at £79.99 for the 0.25mg starter dose (with FIRST40 discount code for new customers), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options like the Intro Trio (0.25mg, 0.5mg & 1mg) provide 12 weeks' supply for £299.99, ensuring consistent treatment progression.
The Wegovy and Mounjaro difference in cost structure reflects their different manufacturers and dosing schedules - while specific Mounjaro pricing varies, both treatments represent significant investment in long-term weight management. Returning customers benefit from DOSE25 discount code, and our GPhC-registered pharmacy (#9012878) ensures you receive authentic prescription-only medicines with proper cold-chain storage and next-day delivery, matching NHS quality standards without the wait.
Clinical Evidence: Wegovy and Mounjaro Difference in Research
The Wegovy and Mounjaro difference becomes clearer when examining clinical trial data, though direct head-to-head comparisons aren't available due to different study populations and endpoints. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021), with sustained benefits observed over 2 years in STEP 5. The SELECT trial additionally demonstrated 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials showed comparable efficacy in their study populations, though the Wegovy and Mounjaro difference lies in tirzepatide's dual mechanism potentially offering enhanced glucose control benefits. Both medications require prescription alongside reduced-calorie diet and increased physical activity, and individual responses may vary significantly regardless of trial averages.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to regulate appetite and food intake. The medication works primarily in your brain's appetite control centres, reducing hunger signals and promoting earlier satiety after smaller meals. This mechanism may also slow gastric emptying, helping you feel fuller for longer periods between meals. Unlike rapid-acting appetite suppressants, Wegovy's once-weekly injection provides consistent appetite regulation throughout the week. The gradual dose escalation from 0.25mg to 2.4mg over 16 weeks allows your body to adapt while minimising potential gastrointestinal side effects that can occur with faster titration schedules.
Private Prescription Ordering Process: Wegovy and Mounjaro Access
EverydayMeds streamlines access to both treatments through our clinical assessment platform, eliminating traditional barriers when considering the Wegovy and Mounjaro difference. The 3-minute online questionnaire covers medical history, current medications, weight management goals, and contraindications, with additional questions specific to each treatment's characteristics. Our qualified prescribers review applications within standard 3 working days (or 24 hours with express service), assessing suitability for either Wegovy or Mounjaro based on individual circumstances. Once approved, medications ship via next-day delivery using temperature-controlled packaging to maintain cold-chain integrity. Our pharmacy team coordinates ongoing prescription management, ensuring seamless dose escalations and maintenance supply without repeated GP appointments or specialist referrals that characterise NHS pathways.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
A practical Wegovy and Mounjaro difference lies in storage flexibility - Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers advantages for travel, work storage, or lifestyle flexibility. The FlexTouch pen delivery system is identical for both medications, with clear dose displays and simple injection mechanisms requiring no mixing or preparation. Dose escalation schedules differ between treatments, with Wegovy following a structured 4-week progression through five doses, while Mounjaro follows its own titration protocol - your prescriber will provide specific guidance based on your chosen treatment and individual tolerance patterns.
Wegovy and Mounjaro Difference: Specialist Support Without NHS Delays
Private prescription eliminates the geographic lottery of NHS tier 3 weight management services, where some areas report 18+ month waiting lists while others offer no specialist provision. Through EverydayMeds, the Wegovy and Mounjaro difference discussion occurs with qualified prescribers familiar with both treatments' profiles, contraindications, and patient selection criteria. This personalised approach allows consideration of factors like diabetes status, cardiovascular risk, previous weight loss medication experience, and lifestyle factors that influence treatment choice.
Our clinical team provides ongoing monitoring support throughout your treatment journey, with prescription renewals handled seamlessly without requiring new GP referrals or specialist appointments. This continuity of care ensures consistent supply during dose escalation phases and maintenance treatment, avoiding the treatment interruptions that can occur when NHS services face capacity constraints or staffing changes affecting specialist clinic availability.
Making Your Choice: Expert Guidance on Treatment Selection
Rather than declaring one treatment superior, the Wegovy and Mounjaro difference comes down to individual patient factors, medical history, and treatment goals that qualified prescribers can assess during clinical evaluation. Both represent prescription-only medicines requiring professional oversight, with distinct mechanisms potentially suiting different patient profiles. EverydayMeds' prescribers consider your complete medical picture when discussing treatment options, ensuring appropriate selection based on evidence-based criteria rather than marketing claims or anecdotal reports. Discount codes FIRST40 (new customers) and DOSE25 (returning customers) apply at checkout to reach our published prices, providing transparent access to both treatments without hidden fees or subscription commitments. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which aligns best with your weight management journey, medical history, and lifestyle requirements for long-term success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
